DSpace logo

Use este identificador para citar ou linkar para este item: http://repositorioinstitucional.uea.edu.br//handle/riuea/4553
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorMaklouf, Luciany de Oliveira-
dc.date.available2023-02-13-
dc.date.available2023-03-03T14:34:37Z-
dc.date.issued2019-06-10-
dc.identifier.urihttp://repositorioinstitucional.uea.edu.br//handle/riuea/4553-
dc.description.abstractPrimary Sjögren's syndrome is a systemic autoimmune disease characterized by lymphocyte infiltration of the exocyanin glands that results in dry eyes and dry mouth, without association with other autoimmune diseases. It affects mainly individuals in the age group of 45 years, with a predilection for the female gender. Although it is one of the most common autoimmune diseases, it is still poorly diagnosed due to the complexity of its etiopathogenesis. The treatment of primary Sjögren's syndrome is multidisciplinary, involving medications that aim to reduce the discomfort caused by xerostomia and Xerophthalmia. The case reported in this study is a framework of primary Sjögren's syndrome, diagnosed in a female patient, who attended the odontological polyclinic of the State University of Amazonas complaining of dry mouth. The excisional biopsy of minor salivary glands was fundamental in the diagnosis of the disease, together with the knowledge of the signs and symptoms of the condition and correct interpretation of the laboratory examspt_BR
dc.languageporpt_BR
dc.publisherUniversidade do Estado do Amazonaspt_BR
dc.rightsAcesso Abertopt_BR
dc.subjectSíndrome de Sjögren;pt_BR
dc.subjectGlândulas salivarespt_BR
dc.subjectXerostomiapt_BR
dc.subjectSalivary glandspt_BR
dc.titleSíndrome de Sjögren primária : relato de casopt_BR
dc.title.alternativePrimary Sjögren's syndrome: case reportpt_BR
dc.typeTrabalho de Conclusão de Cursopt_BR
dc.date.accessioned2023-03-03T14:34:37Z-
dc.contributor.advisor1Vasconcelos II, Antônio Jprge de Araújo-
dc.contributor.advisor1Latteshttp://lattes.cnpq.br/5548562970182242pt_BR
dc.contributor.referee1Vasconcelos II, Antônio Jorge de Araújo-
dc.contributor.referee1Latteshttp://lattes.cnpq.br/5548562970182242pt_BR
dc.contributor.referee2Barros, Mauro Luiz Travessa de-
dc.contributor.referee2Latteshttp://lattes.cnpq.br/3238321047142815pt_BR
dc.contributor.referee3Cabral, Lioney Nobre-
dc.contributor.referee3Latteshttp://lattes.cnpq.br/8956633114853772pt_BR
dc.description.resumoA Síndrome de Sjögren Primária é uma doença autoimune sistêmica caracterizada por infiltração linfocitária das glândulas exócrinas que resulta em olhos secos e boca seca, sem associação com outras doenças autoimunes. Afeta principalmente indivíduos na faixa etária de 45 anos, com predileção pelo sexo feminino. Embora seja uma das doenças autoimunes mais comuns, ainda é pouco diagnosticada devido à complexidade da sua etiopatogenia. O tratamento da Síndrome de Sjögren Primária é multidisciplinar, envolvendo medicações que visam reduzir o desconforto causado pela xerostomia e xeroftalmia. O caso relatado neste trabalho configura-se como um quadro de Síndrome de Sjögren Primária, diagnosticado em uma paciente do sexo feminino, que compareceu à Policlínica Odontológica da Universidade do Estado do Amazonas queixando-se de boca seca. A biópsia excisional de glândulas salivares menores foi fundamental no diagnóstico da enfermidade, juntamente com o conhecimento dos sinais e sintomas da condição e interpretação correta dos exames laboratoriaispt_BR
dc.publisher.countryBrasilpt_BR
dc.relation.references1. Bournia VK, Vlachoyiannopoulos PG. Subgroups of Sjögren syndrome patients according to serological profiles. JournalOfAutoimmunity, 2012 Aug;39(1-2):15-26. doi: 10.1016/j.jaut.2012.03.001 2. Mavragani CP. Mechanisms and new strategies for primary Sjogren's syndrome. Annu. Rev. Med. 2017 Jan;68(14):331–343. doi: 10.1146/annurev-med-043015-123313 3. Seror R, Theander E, Bootsma H, Bowman SJ, Tzioufas A, Gottenberg JE, et al. Outcome measures for primary Sjögren's syndrome: A comprehensive review. J Autoimmun. 2014 Jul;51:51–6. doi: 10.1016/j.jaut.2013.12.010 4. Fox RI. Sjögren's syndrome. The Lancet. 2005 Jul;366(9482):321–31. doi: 10.1016/S0140-6736(05)66990-5 5. Patel R, Shahane A.lin Epidemiol. The epidemiology of Sjögren’s syndrome. Clin Epidemiol 2014 Jul 30;6:247-55 6. Neville B, Damm DD, Allen CM, Chi AC. Patologia Oral e Maxilofacial. 4ª ed. Rio de Janeiro: Elsevier; 2016.. 7. Błochowiak K, Olewicz-Gawlik A, Polańska A, Nowak-Gabryel M, Kocięcki J, Witmanowski H, et al. Oral mucosal manifestations in primary and secondary Sjögren syndrome and dry mouth syndrome. Postepy Dermatol Alergol. 2016 Feb; 33(1): 23–27. doi: 10.5114/pdia.2016.57764 8. Fox PC, Busch KA, Baum BJ. Subjective reports of xerostomia and objective measures of salivary gland performance. J Am Dent Assoc. 1987 Oct;115(4):581–4. 9. Dawes C. Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man. J Dent Res. 1987 Feb;66 Spec No:648–53. doi: 10.1177/00220345870660S107 23 10. Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H et al. American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 2012 apr;64(4):475–87 11. Rasmussen A, Ice JA, Li H, Grundahl K, Kelly JA, Radfar L, et al. Comparison of the American-European Consensus Group Sjögren's syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort. Ann Rheum Dis. 2014 jan;73(1):31–8. doi: 10.1136/annrheumdis-2013-203845 12. Daniels TE, Cox D, Shiboski CH, Schiødt M, Wu A, Lanfranchi H, et al. Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren’s syndrome among 1,726 registry participants. Arthritis Rheum. 2011 Jul;63(7):2021-30. doi: 10.1002/art.30381. 13. Valim V, Trevisani VFM, Pasoto SG, Serrano EV, Ribeiro SLE, Fidelix TSA, et al. Recommendations for the treatment of Sjögren’s syndrome. Rev Bras Reumatol. 2015 SepOct;55(5):446-57. doi: 10.1016/j.rbr.2015.07.004. 14. Both T, Dalm VASH, van Hagen PM, van Daele PLA. Reviewing primary Sjögren’s syndrome: beyond the dryness: From pathophysiology to diagnosis and treatment. Int J MedSci. 2017;14(3):191-200. doi: 10.7150/ijms.17718. 15. Bowman SJ. Sjögren syndrome. Medicine (Abingdon). 2010 Feb; 38(2):105-8. doi:10.1016/j.mpmed.2009.10.011 16. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med. 2004 Jun;164(12):1275-84. doi: 10.1001/archinte.164.12.1275. 17. Valin V, Zandonade E, Pereira AM, Brito Filho OH, Serrano EV, Musso C, et al. Prevalência de Síndrome de Sjögren Primária em importante área metropolitana no Brasil. Revista Brasileira de Reumatologia. 2013;53(1):24-34 23 18. Shoenfeld Y, Blank M, Abu-Shakra M, Amital H, Barzilai O, Berkun Y, et al. The mosaico f autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases – 2008. Isr Med Assoc J. 2008 Jan;10(1):13-9 19. Delaleu N, Jonsson MV, Appel S, Jonsson R. New concepts in the pathogenesis of Sjögren’s syndrome. Rheum Dis Clin North Am. 2008;34(4):833-45. doi: 10.1016/j.rdc.2008.08.004. 20. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002 Jun; 61(6):554-8 21. Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. 2016 American College of Rheumatology/European League against rheumatism classification criteria for primary Sjögren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol. 2017 Jan;69(1):35-45. doi: 10.1002/art.39859 22. Lee J, Koh JH, Kim JW, Sung YK, Lee SS, Choe JY, et al. Performance of the 2016 ACR-EULAR classification criteria for primary Sjogren´s syndrome in a Korea cohort. Rheumatology International. 2018 Jul; Published online; doi: 10.1007/s00296-018-4109-y 23. Tsuboi H, Hagiwara S, Asashima H, Takahashi H, Hirota T, Noma H, et al. Comparison of performance of the 2016 ACR-EULAR classification criteria for primary Sjögren´s syndrome with other sets of criteria in Japanese patients. Ann Rheum Dis. 2017;0:1–6. doi:10.1136/annrheumdis-2016-210758 24. Voulgarelis M, Tzioufas AG, Moutsopoulos HM. Mortality in Sjögren’s syndrome. Clin Exp Rheumatol 2008;26:(5 SuClin Exp Rheumatol 2008;26:(5 Suppl 51):S66-71. 24pt_BR
dc.publisher.initialsUEApt_BR
Aparece nas coleções:ESA - Trabalho de Conclusão de Curso Graduação

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
Síndrome de Sjögren primária -relato de caso.pdf1,89 MBAdobe PDFVisualizar/Abrir
Mostrar registro simples do item Visualizar estatísticas


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.